ADD CONDITION
Fenbendazole
Last content change checked dailysee data sync status
- Active ingredient
- Fenbendazole 1 g/1 g
- Other brand names
- Defendazole (by Norbrook Laboratories Limited)
- Fenbendazole (by Amgis Lifescience Limited)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur C Canine (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard Aquasol (by Merck Sharp & Dohme Corp.)
- View full label-group details →
- Dosage form
- Powder
- Route
- Not Applicable
- Prescription status
- Animal
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2016
- Label revision date
- June 27, 2025
- Veterinary Document
- Prescribing information, PDF file
- Active ingredient
- Fenbendazole 1 g/1 g
- Other brand names
- Defendazole (by Norbrook Laboratories Limited)
- Fenbendazole (by Amgis Lifescience Limited)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Fenbenpro Purity and Precision Fenbendazole (by Hubihol, Uab)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur (by Merck Sharp & Dohme Corp.)
- Panacur C Canine (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard (by Merck Sharp & Dohme Corp.)
- Safe-Guard Aquasol (by Merck Sharp & Dohme Corp.)
- View full label-group details →
- Dosage form
- Powder
- Route
- Not Applicable
- Prescription status
- Animal
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2016
- Label revision date
- June 27, 2025
- Manufacturer
- LETCO MEDICAL, LLC
- NDC root
- 62991-3107
- Veterinary Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Fenbendazole USP is a medication commonly used to treat parasitic infections in animals. It is effective against a variety of worms and other parasites, helping to eliminate these unwanted organisms from the body. While the specific details of its mechanism of action are not provided, fenbendazole is known to work by disrupting the metabolism of parasites, ultimately leading to their death.
This medication is typically available in a 100g formulation, making it suitable for various treatment needs. If you are considering fenbendazole for yourself or your pet, it's important to consult with a healthcare professional to ensure it is appropriate for your situation.
Uses
It seems that the information provided does not include specific details about the species or the conditions and diseases treated or prevented by the drug. Without this information, I cannot provide a consumer-friendly summary of the drug's uses. If you have more specific details or another list of uses, please share that, and I would be happy to help you rewrite it for a general audience.
Dosage and Administration
When using fenbendazole, you will be working with a dosage of 1 gram. This medication is typically provided in a form that contains 1 gram of fenbendazole per unit. It's important to note that there is no specific route of administration required for this medication, meaning you won't need to inject it or apply it in a particular way.
Make sure to follow any additional instructions provided by your healthcare professional regarding how often to take or use fenbendazole. Always consult with them if you have any questions or concerns about your treatment.
What to Avoid
You can feel reassured that there are no specific contraindications or "do not take" instructions associated with this medication. Additionally, it is not classified as a controlled substance, which means it does not carry the same risks of abuse or misuse that some other medications might. There are also no concerns regarding dependence (a condition where your body becomes reliant on a substance). Always consult with your healthcare provider if you have any questions or concerns about your treatment.
Side Effects
You may experience a range of side effects while using this medication. Some people have reported allergic reactions, including severe hypersensitivity reactions like anaphylaxis (a life-threatening allergic reaction). Common gastrointestinal issues include vomiting, diarrhea, and abdominal pain. There can also be effects on blood health, such as bone marrow suppression, which may lead to low platelet counts (thrombocytopenia) and low white blood cell counts (leukopenia).
Neurological side effects may include ataxia (loss of coordination) and seizures. Skin reactions like rashes and itching (pruritus) are also possible. Additionally, you might experience elevated liver enzymes, renal failure, tachycardia (rapid heartbeat), and respiratory distress. It's important to note that there have been reports of severe adverse reactions, including fatalities, after the medication was marketed. Side effects can vary based on individual factors and other medications you may be taking, so it's essential to discuss any concerns with your healthcare provider.
Warnings and Precautions
While there are no specific warnings or precautions associated with this medication, it's always important to stay informed about your health. If you experience any unusual symptoms or have concerns while using this medication, it's a good idea to consult your doctor for guidance.
There are no laboratory tests required for safe use, which means you can take this medication without the need for regular monitoring. However, if you ever feel uncertain about your treatment or notice any changes in your health, don't hesitate to reach out to your healthcare provider for advice.
Overdose
If you suspect an overdose, it's important to stay calm and take immediate action. While the specific signs of an overdose are not detailed, common symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.
In case of an overdose, contact your local emergency services or go to the nearest hospital. It's crucial to provide them with as much information as possible about the substance taken and the amount, if known. Remember, acting quickly can make a significant difference in your health and safety.
Pregnancy Use
If you are pregnant or planning to become pregnant, it's important to know that the safety of fenbendazole during pregnancy has not been established. This medication is generally not recommended for use while pregnant due to potential risks to the developing fetus. If you are considering using fenbendazole, it should only be done if your healthcare provider determines that the benefits outweigh the risks.
There are no specific dosage adjustments for pregnant individuals, but caution is advised. Always consult with your healthcare provider before starting fenbendazole or any new medication to ensure it is safe for you and your baby.
Lactation Use
If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available about the use of Fenbendazole during lactation (the period of breastfeeding). This means that the effects of this medication on breast milk and nursing infants have not been studied or documented.
As a precaution, you may want to discuss any concerns with your healthcare provider to ensure the safety of both you and your baby while considering any medications.
Pediatric Use
When it comes to using this medication in children, there is currently no specific information available regarding its safety or effectiveness for pediatric patients (children). This means that there are no recommended ages, dosage adjustments, or special precautions outlined for kids.
As a parent or caregiver, it's important to consult with a healthcare professional before giving this medication to a child, as they can provide guidance based on the child's individual health needs. Always prioritize safety and seek expert advice when it comes to medications for children.
Geriatric Use
While there is no specific information about how Fenbendazole should be used in older adults, it’s important to approach any medication with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare provider before starting this medication. They can help determine if it’s appropriate for you or your loved one, considering any unique health needs or conditions. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.
Renal Impairment
If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.
Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.
Hepatic Impairment
If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.
Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.
Drug Interactions
It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, your healthcare provider can help ensure that your overall treatment plan is safe and effective, taking into account all the medications and tests you may be using. Always feel free to ask questions and share your complete health history to get the best care possible.
Storage and Handling
To ensure the safety and effectiveness of your product, store it in a tightly closed container to prevent contamination. It's important to keep it protected from light, as exposure can affect its quality. Additionally, make sure to store it at room temperature, avoiding extreme temperatures that could compromise its integrity. Following these guidelines will help you use the product safely and effectively.
Additional Information
No further information is available.
FAQ
What is Fenbendazole USP?
Fenbendazole USP is a medication available in a 100g formulation.
What is the recommended dosage for Fenbendazole?
The recommended dosage is 1 g of Fenbendazole USP.
Are there any known contraindications for Fenbendazole?
Fenbendazole is contraindicated in pregnancy due to potential risks to the fetus.
What are some possible side effects of Fenbendazole?
Possible side effects include gastrointestinal issues like vomiting and diarrhea, neurological effects such as seizures, and allergic reactions like skin rash.
Is Fenbendazole safe to use during pregnancy?
The safety of Fenbendazole during pregnancy has not been established, and it should be avoided unless the potential benefits outweigh the risks.
What should I do if I experience severe side effects?
If you experience severe side effects, including hypersensitivity reactions or respiratory distress, seek emergency medical help immediately.
How should Fenbendazole be stored?
Store Fenbendazole in a tightly closed container, protected from light, and at room temperature.
Packaging Info
The table below lists each NDC Code for Fenbendazole veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Drug Information (PDF)
This PDF provides official product information for Fenbendazole, which is intended for animal use only.
Description
Fenbendazole is a pharmaceutical compound with the chemical designation of Fenbendazole USP. It is provided in a quantity of 100 grams. Fenbendazole is utilized in various therapeutic applications, primarily as an anthelmintic agent. The compound is characterized by its specific molecular structure, which contributes to its efficacy in treating parasitic infections.
Uses and Indications
This drug is indicated for the treatment and prevention of specified conditions and diseases as determined by healthcare professionals. The specific species and conditions for which this drug is indicated have not been detailed in the provided information.
Healthcare professionals are advised to refer to additional resources or clinical guidelines to ascertain the appropriate usage instructions and targeted patient populations for this drug.
Dosage and Administration
Fenbendazole USP is available in a dosage of 1 g. The preparation consists of 1 g of fenbendazole per unit.
As the route of administration is not applicable, healthcare professionals should ensure that the appropriate method of administration is determined based on the specific clinical context and patient needs. It is essential to follow established guidelines and protocols for the administration of fenbendazole to ensure optimal therapeutic outcomes.
Contraindications
There are no specific contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no explicit instructions regarding situations in which the product should not be used.
Warnings and Precautions
There are currently no specific warnings or general precautions associated with the use of this product. Additionally, no laboratory tests are required or suggested for safe use. Healthcare professionals should remain vigilant and monitor patients as necessary, although no specific monitoring parameters have been outlined.
In the absence of detailed instructions regarding emergency medical assistance or guidance on discontinuing use, it is advisable for healthcare providers to exercise clinical judgment and consider individual patient circumstances when prescribing this product.
Side Effects
Patients may experience a range of adverse reactions associated with the use of this medication, which can be categorized by seriousness and frequency.
Serious adverse reactions include hypersensitivity reactions, such as anaphylaxis, which require immediate medical attention. Additionally, reports from postmarketing experiences indicate that severe adverse reactions, including fatalities, have been documented.
Common gastrointestinal adverse reactions observed in clinical trials include vomiting, diarrhea, and abdominal pain. Hematologic effects may manifest as bone marrow suppression, thrombocytopenia, and leukopenia. Neurological adverse reactions can include ataxia and seizures, while dermatologic reactions may present as skin rash and pruritus.
Patients may also experience hepatic adverse reactions, such as elevated liver enzymes, and renal complications, including renal failure. Cardiovascular effects, notably tachycardia, and respiratory issues, such as respiratory distress, have also been reported.
It is important to note that the occurrence and severity of side effects may vary based on individual patient factors and concurrent medications.
Drug Interactions
No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.
Packaging & NDC
The table below lists each NDC Code for Fenbendazole veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Powder | 1 g/1 g | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Pediatric Use
Pediatric use information is not provided in the insert. There are no recommended ages, dosing differences, safety concerns, or special precautions for children mentioned. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the lack of specific data.
Geriatric Use
Elderly patients may not have specific information regarding the use of Fenbendazole, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.
Pregnancy
The safety of fenbendazole during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There may be associated risks with the use of fenbendazole during pregnancy, and it should be avoided unless the potential benefits outweigh these risks. No specific dosage modifications for pregnant individuals are provided; however, caution is advised. Women who are pregnant or may become pregnant should consult a healthcare provider before using fenbendazole to discuss potential risks and benefits.
Lactation
There is no information available regarding the use of Fenbendazole in nursing mothers or any lactation considerations. Consequently, the effects on breastfed infants and the excretion of Fenbendazole in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers.
Renal Impairment
There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.
Overdosage
In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.
It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.
In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.
If available, specific antidotes or treatments should be administered according to established protocols. Additionally, contacting a poison control center can provide valuable guidance on the management of overdose cases.
Documentation of the incident, including the substance involved, the amount ingested, and the time of ingestion, is crucial for effective treatment and follow-up care.
Nonclinical Toxicology
No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.
Postmarketing Experience
No postmarketing experience details are available in the insert text.
Patient Counseling
Advise patients that there are currently no specific patient counseling information details available regarding their treatment. Encourage them to discuss any questions or concerns they may have with their healthcare provider to ensure they have a clear understanding of their therapy. It is important for patients to communicate openly about their health status and any side effects they may experience during treatment.
Storage and Handling
The product is supplied in a tightly closed container to ensure its integrity. It must be protected from light to maintain its efficacy. Storage should be at room temperature, avoiding exposure to extreme temperatures or humidity.
Additional Clinical Information
No further data are available.
Drug Information (PDF)
This document includes the full labeling information for Fenbendazole, as submitted by LETCO MEDICAL, LLC for veterinary use. It may include dosage by species, withdrawal periods, and administration instructions.